Literature DB >> 29578140

Specific White Matter Impairments in Patients with Treatment-Refractory First-Episode Schizophrenia: A 1-Year Follow-up Pilot Study.

Min Chen1, Chuan-Jun Zhuo2, Li-Ju Qian3, Bin Wang3, Jin-Guo Zhai3, Feng Ji3, Xiao-Yan Ke4.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29578140      PMCID: PMC5887755          DOI: 10.4103/0366-6999.228233

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  5 in total

1.  Comparison of a non-stationary voxelation-corrected cluster-size test with TFCE for group-Level MRI inference.

Authors:  Huanjie Li; Lisa D Nickerson; Thomas E Nichols; Jia-Hong Gao
Journal:  Hum Brain Mapp       Date:  2016-10-27       Impact factor: 5.038

2.  Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.

Authors:  Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05

3.  Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects.

Authors:  Sander V Haijma; Neeltje Van Haren; Wiepke Cahn; P Cédric M P Koolschijn; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2012-10-05       Impact factor: 9.306

4.  White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis.

Authors:  Li Yao; Su Lui; Yi Liao; Ming-Ying Du; Na Hu; Joy A Thomas; Qi-Yong Gong
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-05-03       Impact factor: 5.067

5.  Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data.

Authors:  Stephen M Smith; Mark Jenkinson; Heidi Johansen-Berg; Daniel Rueckert; Thomas E Nichols; Clare E Mackay; Kate E Watkins; Olga Ciccarelli; M Zaheer Cader; Paul M Matthews; Timothy E J Behrens
Journal:  Neuroimage       Date:  2006-04-19       Impact factor: 6.556

  5 in total
  1 in total

Review 1.  Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia.

Authors:  Candice E Crocker; Philip G Tibbo
Journal:  Front Pharmacol       Date:  2018-10-18       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.